HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.

Abstract
The efficacy and safety of an extended-release combination of loratadine plus pseudoephedrine sulfate (SCH 434) was compared with that of a tablet containing chlorpheniramine maleate plus pseudoephedrine sulfate (CTM-D) in 131 patients with symptomatic seasonal allergic rhinitis. Patients were randomly assigned to receive either SCH 434 (loratadine 5 mg and pseudoephedrine sulfate 120 mg) or CTM-D (chlorpheniramine maleate 12 mg and pseudoephedrine sulfate 120 mg) twice daily for 2 weeks. Evaluations were made after 3, 7, and 14 days of treatment. Demographics (age, race, sex, and duration of seasonal allergic rhinitis) and baseline total symptom scores were comparable between groups. Both combination products were effective in relieving the symptoms of allergic rhinitis. Improvement in total symptom scores was 54% on day 3 and 65% on day 14 in the SCH 434 group versus 57% on day 3 and 64% on day 14 in the CTM-D group. Individual symptom scores (nasal discharge, stuffiness, nasal itching, sneezing, and ocular symptoms) responded similarly. A smaller proportion of patients in the SCH 434 group reported side effects, especially dry mouth (7% vs 19%, P = 0.07), fatigue (6% vs 25%, P < 0.01), and sedation (7% vs 22%, P < 0.03). In conclusion, the combination of loratadine plus pseudoephedrine sulfate was equally as effective as a classic antihistamine (chlorpheniramine maleate) plus pseudoephedrine sulfate but had a lower incidence of side effects.
AuthorsM Prevost, Y Turenne, D W Moote, J Mazza, A Clermont, C PetitClerc, M R Danzig
JournalClinical therapeutics (Clin Ther) 1994 Jan-Feb Vol. 16 Issue 1 Pg. 50-6 ISSN: 0149-2918 [Print] United States
PMID7911402 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Drug Combinations
  • Histamine H1 Antagonists
  • Sch 434
  • Chlorpheniramine
  • Loratadine
  • Pseudoephedrine
  • Ephedrine
Topics
  • Adolescent
  • Adult
  • Chlorpheniramine (therapeutic use)
  • Drug Combinations
  • Ephedrine (therapeutic use)
  • Female
  • Histamine H1 Antagonists (therapeutic use)
  • Humans
  • Loratadine (therapeutic use)
  • Male
  • Middle Aged
  • Pseudoephedrine
  • Rhinitis, Allergic, Seasonal (drug therapy)
  • Single-Blind Method

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: